Clonidine disposition in children; a population analysis.
Amanda L Potts1, Peter Larsson, Staffan Eksborg
1Department of Anaesthesiology, University of Auckland, New Zealand.
Paediatric Anaesthesia
|September 5, 2007
Summary
Clonidine clearance in neonates is significantly lower than in adults, necessitating dose reduction for this population. This study provides crucial pharmacokinetic data for pediatric clonidine dosing.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Drug Metabolism
Background:
- Limited population pharmacokinetic data exists for clonidine in children (0-15 years).
- Existing pediatric clonidine data inadequately explains inter-individual variability in clinical responses.
- Understanding clonidine pharmacokinetics is crucial for optimizing pediatric treatment.
Purpose of the Study:
- To characterize the population pharmacokinetics of clonidine in children.
- To investigate the influence of age and post-cardiac surgery status on clonidine disposition.
- To provide data for improved pediatric dosing recommendations.
Main Methods:
- Combined data from four studies (intravenous, rectal, epidural administration) with an open-label study in post-cardiac surgery children.
- Population pharmacokinetic analysis using nonlinear mixed effects modeling on 380 time-concentration observations.
- Allometric scaling used to standardize parameter estimates to a 70-kg adult.
Main Results:
- A two-compartment model with first-order elimination best described clonidine disposition.
- Neonatal clearance was approximately one-third of adult values, maturing to 82% of adult rate by one year.
- Volumes of distribution increased post-cardiac surgery; rectal and epidural bioavailability was equivalent with specific absorption characteristics.
Conclusions:
- Neonatal clonidine clearance is immature, necessitating reduced maintenance doses.
- Dosing adjustments are recommended for neonates and infants when targeting specific concentrations.
- Pharmacokinetic insights support more precise pediatric clonidine therapy.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...